Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.
Press releases published on September 16, 2025
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid cancers in combination with other immunotherapies Cancer Research UK’s Centre for Drug Development is sponsoring and managing the …
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
MONTREAL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today that the Company has obtained the final order from the …
Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak
MONTRÉAL, 16 sept. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade de la commercialisation, a annoncé aujourd’hui que la Société a obtenu l’ …
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
WINNIPEG, Manitoba, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or the “Company”) today announces that it has completed a U.S. Food and Drug Administration (“FDA”) 510(k) clearance submission for its revyve® …
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
TEL AVIV, Israel, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress Annual Meeting, taking place from …
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
TORONTO and HAIFA, Israel and INDIANAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical innovator in exosome-based regenerative therapies, is pleased to …
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference …
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market conditions and other factors, $550.0 million aggregate principal amount of …
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
Analyst/Investor event showcases opportunities for KO-2806 (darlifarnib) in combination with PI3Kα inhibitors, KRAS inhibitors and antiangiogenic tyrosine kinase inhibitors (TKIs) Preliminary clinical data and KO-2806 development plans to be presented in …
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
HINGHAM, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) (“Microbot” or the “Company”), today announced the first closing of its previously announced exercise of certain outstanding preferred investment options to purchase up …
Sharecare, AWS, CLEAR, and Georgia Department of Community Health to discuss bringing CMS’s health tech ecosystem vision to life at Health Connect South
ATLANTA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced that its Co-Founder and Executive Chairman Jeff …
WellSpan York Hospital expansion project rises to new heights as final beam is placed
York, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) -- The final steel beam on WellSpan York Hospital’s new eight-story surgical and critical care tower has now been put into place as part of an expansive construction project that will revolutionize advanced …
Cirtec Medical Welcomes Chris Cleary to its Board of Directors
BROOKLYN PARK, Minn., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical is pleased to announce that Chris Cleary has been appointed to its Board of Directors. Chris brings over thirty years of experience in corporate development, mergers and acquisitions, …
Vielight Unveils the First Photobiomodulation-Based Vagus Nerve Stimulation Device Following Patent Approval
Toronto, Ontario, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Toronto, ON — Vielight Inc., a leader in photobiomodulation (PBM) technologies, is pleased to announce the issuance of a utility patent for its device, the Vielight Vagus . This cutting-edge device marks …
New VCF II Impact Report Documents the $4.9 Million Initiative's 68% Cost Reduction While Driving Dramatic Uptake Through Community-Digital Integration
Washington, D.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Global Impact and Advancing Health Online (AHO) today released the Impact Report for the Vaccine Confidence Fund II (VCF II), highlighting breakthrough results from 11 projects that combined digital …
IFM Establishes First-Ever Certifying Board for The Functional Medicine Field
Federal Way, Wash., USA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Institute for Functional Medicine (IFM) today took the next step in the new Functional Medicine Certification Program™ by announcing the formation of the International Board of Functional …
ZKR Orthopedics Announces First Patella LIFT™ Surgeries on the East Coast at Hospital for Special Surgery in Enrollment of FDA PELICAN Trial
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ZKR Orthopedics announced today that the first Patella LIFT™ procedures on the East Coast were successfully performed as part of the PELICAN TRIAL, at the renowned Hospital for Special Surgery (HSS) in New York …
Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight
New York, USA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight The gout market is poised for steady growth, driven by the rising prevalence of the disease, …
UTR Therapeutics Publishes Landmark Preclinical Data in Frontiers in Pharmacology Supporting IND Submission for First-in-Class c-MYC RNA Therapeutic
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- UTR Therapeutics Inc., a biotechnology company advancing a novel RNA Overwriting platform, today announced the peer-reviewed publication of preclinical data in Frontiers in Pharmacology demonstrating compelling …